DE MARIA, Raffaella
 Distribuzione geografica
Continente #
NA - Nord America 5.639
EU - Europa 3.847
AS - Asia 3.246
SA - Sud America 495
AF - Africa 108
OC - Oceania 37
Continente sconosciuto - Info sul continente non disponibili 7
Totale 13.379
Nazione #
US - Stati Uniti d'America 5.534
SG - Singapore 1.369
IT - Italia 1.333
CN - Cina 985
DE - Germania 545
BR - Brasile 399
IE - Irlanda 321
FI - Finlandia 269
FR - Francia 259
SE - Svezia 246
VN - Vietnam 199
GB - Regno Unito 172
KR - Corea 171
JP - Giappone 166
UA - Ucraina 140
PL - Polonia 133
IN - India 110
AT - Austria 109
SN - Senegal 61
CA - Canada 56
ES - Italia 51
NL - Olanda 51
ID - Indonesia 50
HK - Hong Kong 49
MX - Messico 41
BE - Belgio 38
AU - Australia 36
RU - Federazione Russa 35
PT - Portogallo 30
AR - Argentina 29
CH - Svizzera 28
TW - Taiwan 26
BD - Bangladesh 24
CL - Cile 19
TR - Turchia 19
GR - Grecia 16
IQ - Iraq 15
ZA - Sudafrica 14
CO - Colombia 12
TH - Thailandia 10
EC - Ecuador 9
NO - Norvegia 9
RO - Romania 9
LT - Lituania 8
PK - Pakistan 8
HU - Ungheria 7
MA - Marocco 7
UY - Uruguay 7
CZ - Repubblica Ceca 6
PE - Perù 6
UZ - Uzbekistan 6
VE - Venezuela 6
AZ - Azerbaigian 5
DK - Danimarca 5
EU - Europa 5
IR - Iran 5
MC - Monaco 5
MY - Malesia 5
DZ - Algeria 4
EG - Egitto 4
HR - Croazia 4
JO - Giordania 4
LV - Lettonia 4
NG - Nigeria 4
PY - Paraguay 4
SA - Arabia Saudita 4
SI - Slovenia 4
BO - Bolivia 3
CU - Cuba 3
KZ - Kazakistan 3
NP - Nepal 3
TN - Tunisia 3
AL - Albania 2
BG - Bulgaria 2
CR - Costa Rica 2
ET - Etiopia 2
IL - Israele 2
KE - Kenya 2
LB - Libano 2
MD - Moldavia 2
OM - Oman 2
SD - Sudan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
CD - Congo 1
CM - Camerun 1
GA - Gabon 1
GE - Georgia 1
GM - Gambi 1
GT - Guatemala 1
ME - Montenegro 1
NA - Namibia 1
NZ - Nuova Zelanda 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
SV - El Salvador 1
TJ - Tagikistan 1
Totale 13.377
Città #
Singapore 680
Chandler 529
Beijing 490
Ashburn 402
Dublin 321
Torino 314
Fairfield 289
Santa Clara 286
Ann Arbor 270
Houston 239
Woodbridge 174
Munich 172
Wilmington 160
Seattle 144
Villeurbanne 137
Pisa 125
Medford 118
Nyköping 117
Redwood City 117
Cambridge 116
Warsaw 116
Dearborn 110
Princeton 109
Turin 106
Los Angeles 104
Columbus 96
Jacksonville 93
Vienna 78
Helsinki 75
Dallas 68
Milan 62
Buffalo 59
Tokyo 59
Guangzhou 55
Pune 54
Boardman 52
Hefei 50
Boston 48
Dong Ket 47
Fremont 46
Jakarta 42
São Paulo 41
Seoul 40
New York 39
Ho Chi Minh City 38
Hong Kong 37
The Dalles 36
Turku 36
Nanjing 33
Redondo Beach 28
Brussels 27
San Diego 25
Philadelphia 23
Hanoi 22
Shanghai 22
Silver Spring 22
Toronto 21
Bologna 19
Frankfurt am Main 19
Norwalk 19
Rome 18
London 17
Utrecht 16
Nuremberg 15
Falls Church 14
Shenyang 14
Taipei 14
Bengaluru 13
Hangzhou 13
Nürnberg 13
Rio de Janeiro 13
Wuhan 13
Chongqing 12
Davis 12
Verona 12
Brooklyn 11
Camerino 11
Denver 11
Genoa 11
Kunming 11
Phoenix 11
Bottanuco 10
Council Bluffs 10
Des Moines 10
Hebei 10
Jinan 10
Mexico City 10
Osaka 10
Padova 10
Stockholm 10
West Lafayette 10
Zurich 10
Columbia 9
Florence 9
Lappeenranta 9
Lisbon 9
Oslo 9
Atlanta 8
Leawood 8
Napoli 8
Totale 7.730
Nome #
Prolongation of survival of dogs with oral malignant melanoma treated by en bloc surgical resection and adjuvant CSPG4-antigen electrovaccination 646
PDGFR-α, PDGFR-β, VEGFR-2 and CD117 expression in canine mammary tumours and evaluation of the in vitro effects of toceranib phosphate in neoplastic mammary cell lines. 435
PDGFRs expression in dogs affected by malignant oral melanomas: correlation with prognosis 405
Chondroitin sulfate proteoglycan 4: A biomarker and potential immunotherapeutic target for canine malignant melanoma 381
CSPG4-specific immunity and survival prolongation in dogs with oral malignant melanoma immunized with human CSPG4 DNA 377
CSPG4: a prototype oncoantigen for translational immunotherapy studies 310
In vitro and in vivo effects of toceranib phosphate on canine osteosarcoma cell lines and xenograft orthotopic models 308
In vitro and in vivo characterization of stem-like cells from canine osteosarcoma and assessment of drug sensitivity 290
Activation of AKT2 in feline mammary carcinoma: a new prognostic factor in feline mammary tumors 270
PDGFs/PDGFRs in canine osteosarcomas: new targets for innovative therapeutical strategies in comparative oncology 269
Attività ed espressione dell'enzima 3-beta-idrossisteroide deidrogenasi in testicoli sani e criptorchidi di suino 259
Activation of mammalian target of rapamycin (mTOR) in triple negative feline mammary carcinomas 224
Expression of the Short Form of RON/STK in Feline Mammary Carcinoma 223
Corticosteroid Hormone Receptors and Prereceptors as NewBiomarkers of the Illegal Use of Glucocorticoids in Meat Production 219
Isolation, purification, culture and characterisation of myoepithelial cells from normal and neoplastic canine mammary glands using a magnetic-activated cell sorting separation system. 201
IN-VITRO ESTABLISHMENT AND CHARACTERIZATION OF MYOEPITHELIAL CELL LINES FROM FOUR CANINE MAMMARY CARCINOMAS AND TWO NORMAL MAMMARY GLANDS 195
Inter-laboratory comparison of a yeast bioassay for the determination of estrogenic activity in biological samples 191
Circulating Cell-Free DNA in Dogs with Mammary Tumors: Short and Long Fragments and Integrity Index 190
Met oncogene activation qualifies spontaneous canine osteosarcoma as a suitable pre-clinical model of human osteosarcoma 182
Identification of CSPG4 as a promising target for translational combinatorial approaches in osteosarcoma 180
Progesterone receptor up-regulation: a diagnostic tool for the illicit use of oestrogens in adult beef cattle. 167
17beta-oestradiol-induced gene expression in cattle prostate: biomarkers to detect illegal use of growth promoters 167
Immunohistochemical investigation of cell cycle and apoptosis regulators (survivin, β-catenin, p53, caspase 3) in canine appendicular osteosarcoma. 159
Increased expression of insulin-like growth factor-1 receptor is correlated with worse survival in canine appendicular osteosarcoma 155
Heat shock protein expression in canine osteosarcoma 148
Application of absolute qPCR as a screening method to detect illicit 17-betaestradiol administration in male cattle 148
17-AAG and Apoptosis, Autophagy, and Mitophagy in Canine Osteosarcoma Cell Lines 148
Progesterone receptor gene expression in the accessory sex glands of veal calves 138
A RIKILT yeast estrogen bioassay (REA) for estrogen residue detection in urine of calves experimentally treated with 17-betaestradiol. 134
Canine osteosarcoma cell lines contain stem-like cancer cells: biological and pharmacological characterization 134
Clinical significance and in vitro cellular regulation of hypoxia mimicry on HIF-1α and downstream genes in canine appendicular osteosarcoma 130
Expression of PDGFRs receptors in canine mammary carcinomas: pathological and clinical implications 128
MUCOPOLYSACCHARIDOSIS VI IN A SIAMESE/SHORT-HAIRED EUROPEAN CAT 126
Attivazione e caratterizzazione molecolare dell’oncogene AKT nei tumori mammari felini. 123
Transcriptome Analysis of Canine Cutaneous Melanoma and Melanocytoma Reveals a Modulation of Genes Regulating Extracellular Matrix Metabolism and Cell Cycle 119
A NEW FORM OF GMI-GANGLIOSIDOSIS IN TWO KORAT CATS 119
Immunohistochemical and quantitative RT-PCR methods to assess RANK expression in normal and neoplastic canine mammary gland 116
Progesterone receptor gene over-expression in target organs following 17beta-estradiol treatment in veal calves 116
Difference in outcome between curative intent vs marginal excision as a first treatment in dogs with oral malignant melanoma and the impact of adjuvant CSPG4-DNA electrovaccination: A retrospective study on 155 cases 114
Effects of Two Concentrations of a Clinical Propofol Formulation on Canine Mammary Tumor Cells NET1 Gene Expression: A Preliminary Evaluation of Possible Anti-Metastatic Properties 113
Valutazione dell'espressione del recettore del progesterone tramite qPCR assoluta nei bovini 111
Mucopolysaccharidosis VI in a Siamese/short-haired European cat. 111
Mucopolysaccaridosis VI in a Siamese/short-haired European cat 110
Response to toceranib in dogs with measurable, unresectable, recurrent or metastatic mammary carcinomas 110
Difference in outcome between curative intent vs marginal excision as a first treatment in dogs with oral malignant melanoma and the impact of adjuvant CSPG4-DNA electrovaccination: A retrospective study on 155 cases 110
Beta Galactosidase deficiency in a Korat cat: a new form of feline GM1 gangliosidosis 108
Valutazione dell’espressione genica dell’enzima 11betaHSD 1 e 2 in colture di adipociti bovini trattati con desametazone e prednisolone. 108
Co-expression of PDGFR Alpha and Beta in Canine Osteosarcomas Cell Lines and Tissues: New Targets for Innovative Therapeutic Strategies. 104
Identification of potential biomarkers for the illegal glucocorticoids treatment in cattle 101
Progesteron receptor gene up-regulation: a screening tool to detect estrogen illicit use in beef cattle 100
TP53 EXPRESSION AND ANALYSIS OF SINGLE NUCLEOTIDE POLYMORPHISM (SNPS) IN FELINE SQUAMOUS CARCINOMAS 99
I modelli animali spontanei per lo studio della fisiologia e patologia dell'uomo 99
Expression of mammalian target of rapamycin (mTOR) in feline mammary tumors: a potential target therapy in triple negative cancer 97
Correlation of PDGFRs with histotype and clinical outcome in canine thyroid carcinoma 92
met oncogene activation qualifies spontaneous canine osteosarcoma as a suitable pre-clinical model of human osteosarcoma 91
Genomic and Transcriptomic Characterization of Canine Osteosarcoma Cell Lines: A Valuable Resource in Translational Medicine 91
Canine mammary tumour cells exposure to sevoflurane: effects on proliferation and neuroepithelial transforming gene 1 expression 88
Molecular characterization and activation of AKT oncogene in feline mammary tumors 87
Procedimento e Kit per la rilevazione della somministrazione di sostanze estrogeniche esogene nei bovini 86
PDGFR expression is correlated to worse prognosis in dogs affected by malignant oral melanomas 85
Ruolo del pathway PDGFRs/PDGFs nell'osteosarcoma canino: studio di bersagli molecolari per strategie terapeutiche innovative. 83
OXT gene up-regulation in bovine skeletal muscle induced by dexamethasone and 17-beta-estradiol. 83
Platelet derived growth factor receptors expression in dogs affected by malignant oral melanomas: correlation with prognosis 83
VACCINATION WITH HUMAN HMW-MAA DNA INDUCES A SPECIFIC ANTIBODY RESPONSE IN DOGS WITH MELANOMASIC 82
Expression of mammalian target of rapamycin (mTOR) in feline mammary tumors: a potential target therapy in triple negative tumors 82
THE PRESENCE OF SHORT FORM OF RON/STK TRANSCRIPT COULD BE A PREDICTOR OF POOR OUTCOME IN FELINE MAMMARY CARCINOMA 81
Hypoxia-associated markers in the prognosis of oral canine melanoma 80
Espressione dell’ HMW-MAA nei melanoma orali canini come potenziale target terapeutico nell’immunoterapia. 79
Overexpression of c.Met oncogene in canine osteosarcomas and cells lines 78
Doxorubicin treatment modulates chemoresistance and affects the cell cycle in two canine mammary tumour cell lines 76
The genomic landscape of canine diffuse large B-cell lymphoma identifies distinct subtypes with clinical and therapeutic implications 75
Feline stk gene expression in cat mammary carcinomas 75
PCNA overexpression in bovine experimentally treated with 17 beta estradiol 75
Exploring the dynamics of Programmed Death-Ligand 1 in canine lymphoma: unraveling mRNA amount, surface membrane expression and plasmatic levels 73
PDGFS/PDGFRs in canine osteosarcomas: new targets for innovative therapeutical strategies in comparative oncology 72
The heat Shock Protein 90 inhibitor 17-AAG induces antiproliferative and apoptotic effects in canine osteosarcoma cell lines 72
An Update on Molecular Pathways Regulating Vasculogenic Mimicry in Human Osteosarcoma and Their Role in Canine Oncology 72
Tumour grading and the one year post-surgical prognosis in feline mammary carcinomas. 71
PDGFR receptors: new targeted therapy in canine osteosarcoma 69
IMMUNOHISTOCHEMICAL EXPRESSION OF MATRIX METALLOPROTEINASE 2 (MMP-2) IN FELINE FIBROADENOMATOUS CHANGE 69
The presence of the short form of RON/STK transcript is a prognostic factor of poor outcome in feline mammary carcinomas 69
Prognostic Significance of Microvessel Density and Hypoxic Markers in Canine Osteosarcoma: Insights into Angiogenesis and Tumor Aggressiveness 67
Ki-67 index as indicator of the post-surgical prognosis in feline mammary carcinomas. 67
RON and MET oncogene expression in cat mammary tumors 67
Gene expression induced by 17 estradiol in bovine prostatic stromal cells: a way for the identification of molecular markers involved in the illegal use of growth promoters 65
Predicting outcome in dogs with diffuse large B-cell lymphoma with a novel immune landscape signature 63
Spontaneous feline mammary carcinoma is a model of HER2 overexpressing poor prognosis human breast cancer 63
I tumori spontanei negli animali come modelli di studio per l'oncologia comparata 62
The mitotic regulator polo-like kinase 1 as a potential therapeutic target for c-Myc-overexpressing canine osteosarcomas 61
Gene expression induced by 17b-estradiol in bovine cultured stromal cells 61
HEAT SHOCK PROTEIN EXPRESSION IN CANINE OSTEOSARCOMA 60
Molecular and immunohistochemical studies on RON and MET oncogenes in cat mammary tumors 59
RON and MET oncogene expression in cat mammary tumors 59
Lesioni indotte dalla somministrazione illecita di promotori della crescita negli animali da carne 59
Role of betha catenin in canine osteosarcoma 59
Ultrastructural Investigation of Canine osteosarcoma Cells killed by 17-AGG (17 Allylamino 17- demethoxygeldanamycin) through autophagy/apoptosia/necrosis 58
E-Cadherin Expression in Canine Melanocytic Tumors: Histological, Immunohistochemical, and Survival Analysis 57
Expression of alpha and beta estrogen receptor in veal cattle treated with clenbuterol. 54
PDGF RECEPTORS AS PREDICTOR OF OUTCOME IN CANINE ORAL MELANOMAS 53
Thinking Outside the Box: Indirect Myc Modulation in Canine B-Cell Lymphoma 52
Totale 13.190
Categoria #
all - tutte 39.939
article - articoli 0
book - libri 0
conference - conferenze 12.468
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.407


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021742 0 0 0 0 0 97 84 48 158 145 58 152
2021/20221.169 65 58 72 56 44 62 82 64 36 112 257 261
2022/20231.659 176 135 38 149 179 416 128 95 163 42 87 51
2023/2024771 111 111 44 40 44 140 34 42 3 45 56 101
2024/20252.483 33 128 92 190 540 161 131 145 353 153 174 383
2025/20262.040 466 210 307 502 501 54 0 0 0 0 0 0
Totale 13.800